Neurogene(NGNE)
$23.93+0.03 (+0.13%)
NGNE
Neurogene financials statements
$23.93
At close:+0.03 (+0.13%)
Want to see NGNE full AI Analyst Report?
Neurogene (NGNE) Income Statement
652 Followers
Neurogene Income Statement
Last quarter (Q3 2026), Neurogene's total revenue was $0.00. In Q3, Neurogene's net income was $-29.02M. See Neurogene’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 925.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -3.19M | $ -2.32M | $ -3.26M | $ -3.20M | $ -42.26M | |
| $ 100.02M | $ 80.28M | $ 52.32M | $ 53.32M | $ 8.27M | |
| Depreciation and Amortization | $ 3.09M | $ 3.25M | $ 3.30M | $ 3.20M | $ 947.00K |
| $ -87.25M | $ -71.89M | $ -33.01M | $ -51.99M | $ -49.57M | |
| $ -103.21M | $ -82.61M | $ -55.58M | $ -56.52M | $ -50.53M | |
| $ 12.86M | $ 7.46M | $ 19.27M | $ 1.33M | $ 17.00K | |
| $ -90.35M | $ -75.14M | $ -36.32M | $ -55.19M | $ -50.52M | |
| $ -90.35M | $ -75.14M | $ -36.32M | $ -55.19M | $ -50.52M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.24 | $ -4.28 | $ -2.83 | $ -4.30 | $ -0.92 |
| Diluted EPS | $ -4.24 | $ -4.28 | $ -2.83 | $ -4.30 | $ -0.92 |
| Weighted Average Shares Outstanding | 21.17M | 17.57M | 12.82M | 12.82M | 55.04M |
| Weighted Average Shares Outstanding (Diluted) | 21.17M | 17.57M | 12.82M | 12.82M | 55.04M |
Currency in USD

